Literature DB >> 33868655

Hepatic Venous Pressure Gradient.

Teodora Bochnakova1.   

Abstract

Entities:  

Year:  2021        PMID： 33868655      PMCID： PMC8043695          DOI： 10.1002/cld.1031

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  23 in total

1.  Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension.

Authors:  Susana Seijo; Enric Reverter; Rosa Miquel; Annalisa Berzigotti; Juan G Abraldes; Jaume Bosch; Juan Carlos García-Pagán
Journal:  Dig Liver Dis       Date:  2012-06-19       Impact factor: 4.088

2.  Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding.

Authors:  C Villanueva; J Ortiz; J Miñana; G Soriano; M Sàbat; J Boadas; J Balanzó
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

Review 3.  Hepatic venous pressure gradient measurement in clinical hepatology.

Authors:  Carlo Merkel; Sara Montagnese
Journal:  Dig Liver Dis       Date:  2011-05-06       Impact factor: 4.088

Review 4.  What's new in portal hypertension?

Authors:  Ezequiel Mauro; Adrián Gadano
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

Review 5.  Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage.

Authors:  Julio D Vorobioff; Roberto J Groszmann
Journal:  Ann Hepatol       Date:  2013 Jan-Feb       Impact factor: 2.400

6.  Risk factors for early rebleeding and mortality in acute variceal hemorrhage.

Authors:  Jing-Run Zhao; Guang-Chuan Wang; Jin-Hua Hu; Chun-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

7.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

8.  Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.

Authors:  F Feu; J C García-Pagán; J Bosch; A Luca; J Terés; A Escorsell; J Rodés
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

Review 9.  Hepatic venous pressure gradient: clinical use in chronic liver disease.

Authors:  Ki Tae Suk
Journal:  Clin Mol Hepatol       Date:  2014-03-26

Review 10.  Managing portal hypertension in patients with liver cirrhosis.

Authors:  Tilman Sauerbruch; Robert Schierwagen; Jonel Trebicka
Journal:  F1000Res       Date:  2018-05-02
View more
  5 in total

1.  A Case Report of Nodular Regenerative Hyperplasia and Non-cirrhotic Portal Hypertension Post Oxaliplatin Chemotherapy.

Authors:  Nagapratap Ganta; Ankita Prasad; Mina Aknouk; Kajal Ghodasara; Ambica Nair; Zehra Taqvi; Pramil Cheriyath
Journal:  Cureus       Date:  2022-09-03

2.  Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia.

Authors:  Daniel V DiGiacomo; Jessica E Shay; Rory Crotty; Nancy Yang; Patricia Bloom; Kathleen Corey; Sara Barmettler; Jocelyn R Farmer
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  The severity of portal hypertension by a non-invasive assessment: acoustic structure quantification analysis of liver parenchyma.

Authors:  Wen-Bin Cai; Ji-Kai Yin; Qiao-Ying Li; Yi-Lin Yang; Yun-You Duan; Li Zhang
Journal:  BMC Med Imaging       Date:  2022-05-12       Impact factor: 2.795

4.  Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes.

Authors:  Aboelyazid Elkilany; Mohamed Alwarraky; Timm Denecke; Dominik Geisel
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

5.  Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis.

Authors:  Lukas Sturm; Dominik Bettinger; Lisa Roth; Katharina Zoldan; Laura Stolz; Chiara Gahm; Jan Patrick Huber; Marlene Reincke; Rafael Kaeser; Tobias Boettler; Wolfgang Kreisel; Robert Thimme; Michael Schultheiss
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.